News

Emyria’s Managing Director, Dr Michael Winlo reflects on a great quarter

February 2, 2021

Emyria’s Managing Director, Dr Michael Winlo reflects on a great quarter in the Appendix 4C ASX Annoucement.

Read the full announcement here

Buoyed by our financial and operational strength, Emyria is focused on advancing the development and commercialisat… https://t.co/MBNSGYnrkm

We are pleased to release the 1H FY2021 Results highlighting our strategic investments into R&D has enabled $EMD to… https://t.co/4JLHj12wD0

Emyria appoints global pharmaceutical expert, Dr Karen Smith, to chair Strategic Advisory Board boosting our global… https://t.co/JHR0cau96X